logo
Share SHARE
FONT-SIZE Plus   Neg

CVS Caremark Reaches Civil Settlement With DOJ On RxAmerica

CVS Caremark Corp. (CVS) said Monday that it has reached a civil settlement with the United States Department of Justice regarding its investigation into certain business practices of a subsidiary of Longs Drug Stores Corp. which began prior to the acquisition of Longs by CVS Caremark in October 2008.

Pursuant to the settlement agreement, RxAmerica has expressly denied any liability.

The settlement resolves allegations that, in 2007 and 2008, Medicare Part D paid claims related to RxAmerica's submission of inaccurate pricing data to the Centers for Medicare & Medicaid Services for use in estimating prescription drug prices on the CMS website tool, Plan Finder, for certain generic drugs covered by a Medicare Part D Prescription Drug Plan sponsored by RxAmerica. The settlement also resolves all allegations in a related federal qui tam complaint filed by certain of the Part D Plan members.

The settlement includes a payment of $5.25 million to the Department of Justice, plus costs and other fees.

Those payments have been fully accrued for and will not affect the company's 2012 earnings results, CVS Caremark said.

The company said it agreed to settle the matter in order to avoid the burden and expense of continuing litigation.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Tech companies are joining a growing backlash in Silicon Valley against the cyber presence of neo-Nazis and other hate groups after Charlottesville attack. The companies, including Apple, Facebook and Reddit, are beginning to take action after the tragedy highlighted neo-Nazi communities across the internet. Mortgage rates are continuing to hold at low levels amidst ongoing economic uncertainty, mortgage provider Freddie Mac announced Thursday. The 30-year fixed-rate mortgage averaged 3.89% with an average 0.4 point during the week ending August 17, down from 3.90% in the prior week. It is now just one basis point above its 2017 low. Shares of Infosys Technologies Ltd. were losing around 10 percent in Indian trading on Friday after the Software exporter announced that Vishal Sikka has resigned as the Managing Director and Chief Executive Officer with immediate effect. The company appointed current chief operating officer Pravin Rao as the Interim-Managing Director and Chief Executive Officer.
comments powered by Disqus
Follow RTT